focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,130.00
Bid: 12,128.00
Ask: 12,130.00
Change: -42.00 (-0.35%)
Spread: 2.00 (0.016%)
Open: 12,180.00
High: 12,198.00
Low: 12,076.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: UK Aims For 14 Million To Be Offered Covid Jab By Mid-Feb

Tue, 05th Jan 2021 06:49

(Alliance News) - Almost 14 million people in the UK could be in line for a Covid vaccine by the middle of February, in line with plans announced by the prime minister.

In a TV address announcing the third national lockdown for England, Boris Johnson said officials were hoping for all people in the top four priority groups to have been offered a jab in the coming weeks.

Tweeting afterwards, vaccine minister Nadhim Zahawi said the NHS "family will come together" to get 13.9 million doses prepared for the most vulnerable by the middle of next month.

A source told the PA news agency that those near the top of the list will be contacted by mid-February, but the final figure could be lower – closer to 13 million – because of some crossover between groups, such as those over 80 who live in care homes.

Speaking from Downing Street, Johnson outlined the NHS's "realistic expectations" for the vaccination programme in the coming weeks.

He said: "By the middle of February, if things go well and with a fair wind in our sails, we expect to have offered the first vaccine dose to everyone in the four top priority groups identified by the Joint Committee on Vaccination & Immunisation."

Theoretically, this means that all people over the age of 70 should expect to have an inoculation soon, as well as healthcare staff and others who are vulnerable.

Top of the priority list are people who live and work in care homes, followed by people over the age of 80 and frontline health and social care workers – including NHS staff.

Next on the list are people over the age 75, and the fourth group are people aged 70 and those classed as clinically extremely vulnerable.

This last group – who are the same as those who have been advised to shield – includes people such as organ transplant recipients and cancer patients.

Johnson said of the top four priority groups: "If we succeed in vaccinating all those groups, we will have removed huge numbers of people from the path of the virus".

"And of course that will eventually enable us to lift many of the restrictions we've endured for so long."

The news comes on the same day the first patients received the Oxford University and AstraZeneca PLC jab, which is now being handed out alongside the Pfizer Inc vaccine.

Johnson referred to the existence of the vaccines as the "one huge difference" in fighting the pandemic now compared to last year.

"We're now rolling out the biggest vaccination programme in our history," he added.

Hospitality businesses have pledged to help with the rollout, offering their spaces which are currently unused due to ongoing closures.

Calling for more grants as premises remain shuttered, UKHospitality Chief Executive Kate Nicholls said businesses are "keen to repay the support shown to us".

She explained: "Our sector is sitting on well-ventilated, Covid-secure spaces such as hotels, conference centres, pubs and restaurants which can be used and businesses are already coming forward to offer locations to expedite a mass vaccination programme."

By Caitlin Doherty, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.